HJ
Highly rated in
5
conditions

Dr. Heather A. Jacene

Brigham And Women's Faulkner Hospital
Boston, MA
Highly rated in
5
conditions
Specialties:Nuclear Medicine | Radiology
Experience:22 Years
Clinical Trials:Currently Recruiting for 3 Trials
Accepts:New PatientsMedicare
Highly rated in
5
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Heather A. Jacene's experience treating your condition:
About Dr. Heather A. Jacene

Heather Jacene is a Nuclear Medicine specialist and a Radiologist in Boston, Massachusetts. Jacene has been practicing medicine for over 22 years and is highly rated in 5 conditions, according to our data. Her top areas of expertise are Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), WT1-Related Wilms Tumor Syndromes, and Renal Cell Carcinoma (RCC). She is licensed to treat patients in Massachusetts and Maryland. Jacene is currently accepting new patients.

Her clinical research consists of co-authoring 99 peer reviewed articles and participating in 7 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Heather A. Jacene it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Heather A. Jacene accepts the following insurance:

  •  Ambetter
Call to see if your plan is accepted.
Locations
1153 Centre St, Boston, MA 02130
Other Locations
75 Francis St, Boston, MA 02115
450 Brookline Ave, Boston, MA 02215
Background & Education
Graduate Institution
Rutgers R W Johnson Medical School (Cam/new Bruns/pisc), 2001
Specialties
Nuclear Medicine
Radiology
Licenses
Nuclear Medicine in MA
Hospital Affiliations
Brigham And Womens Hospital
Dana Farber Cancer Institute
Brigham And Womens Faulkner Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials
A Phase I Trial of Triapine and Lutetium Lu 177 Dotatate in Combination for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Enrollment Status: Recruiting
Publish Date: December 01, 2022
Intervention Type: Procedure, Drug
Study Drugs: Lutetium Lu 177 DotatateTriapine
Study Phase: Phase 1
FDG PET to Assess Therapeutic Response in Patients With Bone-Dominant Metastatic Breast Cancer, FEATURE
Enrollment Status: Recruiting
Publish Date: September 30, 2022
Intervention Type: Other, Procedure
Study Phase: Phase 2
A Pilot Study of 18Fluorine-Fluciclovine Positron Emission Tomography/Computed Tomography for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Enrollment Status: Recruiting
Publish Date: April 05, 2022
Intervention Type: Drug, Device
Study Drug: 18F-Fluciclovine
Study Phase: Early Phase 1
A Phase II, Open Label, Multi-Dose Study of ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for Positron Emission Tomography (PET/CT) in Patients With Selected Advanced or Metastatic Solid Malignancies Who Are Scheduled to Receive Standard-of-Care Immunotherapy Only, As Single Agent or in Combination
Enrollment Status: Completed
Publish Date: November 17, 2022
Intervention Type: Drug
Study Drug: 89Zr-Df-IAB22M2C
Study Phase: Phase 2
Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
Enrollment Status: Completed
Publish Date: December 12, 2019
Intervention Type: Drug, Procedure
Study Phase: Early Phase 1
A Phase I/II Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: August 01, 2018
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 1/2 Multi-Center, Safety and Efficacy Study Evaluating Intravenously Administered 131I-TM601 in Patients With Progressive and/or Recurrent Malignant Glioma
Enrollment Status: Unknown status
Publish Date: July 17, 2009
Intervention Type: Drug
Study Drug: 131I-TM601
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials -
99 Total Publications
Lutetium Lu 177 vipivotide tetraxetan for metastatic castration-resistant prostate cancer.
Journal: Expert review of anticancer therapy
Published: October 28, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
SD
Dr. Sharmila Dorbala
Radiology | Cardiology
Highly rated in
18
conditions
Radiology
Cardiology

Brigham Health

Brigham And Women's Faulkner Hospital

1153 Centre St, 
Boston, MA 

Sharmila Dorbala is a Radiologist and a Cardiologist in Boston, Massachusetts. Dorbala has been practicing medicine for over 34 years and is highly rated in 18 conditions, according to our data. Her top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Coronary Heart Disease, Heart Transplant, and Coronary Artery Bypass Graft (CABG). She is licensed to treat patients in Massachusetts. Dorbala is currently accepting new patients.

JM
Dr. Jana E. Montgomery
Nuclear Medicine | Cardiology
Highly rated in
35
conditions
Nuclear Medicine
Cardiology

Beth Israel Lahey Health

Lahey Hospital & Medical Center

41 Mall Rd, 
Burlington, MA 
 13.2 mi

Jana Montgomery is a Nuclear Medicine specialist and a Cardiologist in Burlington, Massachusetts. Montgomery has been practicing medicine for over 17 years and is highly rated in 35 conditions, according to our data. Her top areas of expertise are Atrial Fibrillation, Pulmonary Embolism, Arterial Embolism, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). She is licensed to treat patients in Massachusetts. Montgomery is currently accepting new patients in some locations.

JS
Dr. James A. Scott
Nuclear Medicine | Radiology
Highly rated in
4
conditions
Nuclear Medicine
Radiology

Mass General Brigham

Radiological Associates

55 Fruit St, 
Boston, MA 
 5.2 mi

James Scott is a Nuclear Medicine specialist and a Radiologist in Boston, Massachusetts. Scott has been practicing medicine for over 47 years and is highly rated in 4 conditions, according to our data. His top areas of expertise are Caffey Disease, Smoldering Multiple Myeloma, WT1-Related Wilms Tumor Syndromes, and Lung Nodules. He is licensed to treat patients in Massachusetts.